定量扩散加权成像鉴别颈部淋巴瘤性、转移性与非恶性淋巴结病变:系统综述与Meta分析
该系统综述与Meta分析纳入27项研究、1165例患者,比较颈部淋巴瘤性、转移性与非恶性淋巴结的平均ADC值。淋巴瘤性淋巴结ADC低于转移性,转移性低于非恶性,标准化均数差分别为-1.36和-1.61。应用ADC阈值可鉴别淋巴瘤性与转移性(DOR 52.07,sROC AUC 0.936)及转移性与非恶性(DOR 39.45,sROC AUC 0.929)。
要点
- 淋巴瘤性淋巴结平均ADC低于转移性,转移性低于非恶性淋巴结。
- ADC阈值鉴别淋巴瘤性与转移性淋巴结的sROC AUC为0.936。
- ADC阈值鉴别转移性与非恶性淋巴结的sROC AUC为0.929。
核心结论
- 定量评估ADC有助于鉴别可疑颈部淋巴结,尤其适用于无恶性肿瘤病史或原发灶不明的患者。
研究设计与样本
- 系统综述与Meta分析,检索Ovid MEDLINE、EMBASE、Cochrane Central Register of Controlled Trials和Web of Science Core Collection,纳入27项比较颈部淋巴结平均ADC的研究,共1165例患者,包含225枚淋巴瘤性、1162枚转移性和1333枚非恶性淋巴结,采用随机效应模型计算标准化均数差和95%CI。
诊断标准与关键数值
- 淋巴瘤性 vs 转移性淋巴结平均ADC的标准化均数差为-1.36(95%CI:-1.71至-1.01,p<0.0001)。
- 转移性 vs 非恶性淋巴结平均ADC的标准化均数差为-1.61(95%CI:-2.19至-1.04,p<0.0001)。
- 应用ADC阈值鉴别淋巴瘤性与转移性淋巴结的DOR为52.07(95%CI:25.45-106.54),sROC AUC为0.936(95%CI:0.896-0.979)。
- 应用ADC阈值鉴别转移性与非恶性淋巴结的DOR为39.45(95%CI:16.92-92.18),sROC AUC为0.929(95%CI:0.873-0.966)。
临床应用与阅片要点
- 定量ADC测量可辅助鉴别颈部可疑淋巴结,尤其在无恶性肿瘤病史或原发灶不明的患者中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To perform a systematic review and meta-analysis of literature comparing average apparent diffusion coefficient (ADC) for differentiating lymphomatous, metastatic, and non-malignant cervical lymphadenopathy.
METHODS: We performed a comprehensive literature search of Ovid MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science Core Collection. Studies comparing average ADC of lymphomatous, metastatic, and non-malignant neck lymph nodes were included. The standardized mean difference and 95% confidence interval (CI) was calculated using random-effects models. In subgroup analysis of those studies applying ADC threshold for differentiation of cervical lymphadenopathy, pooled diagnostic odds ratio (DOR) and summary receiver operating characteristics (sROC) area under the curve (AUC) were determined.
RESULTS: A total of 27 studies with 1165 patients were included, pooling data from 225 lymphomatous, 1162 metastatic, and 1333 non-malignant cervical lymph nodes. The average ADC values were lower in lymphomatous compared to metastatic nodes, and in metastatic compared to non-malignant nodes with a standardized mean difference of - 1.36 (95% CI: - 1.71 to - 1.01, p < 0.0001) and - 1.61 (95% CI: - 2.19 to - 1.04, p < 0.0001), respectively. In subgroup analysis, applying ADC threshold could differentiate lymphomatous from metastatic lymphadenopathy with DOR of 52.07 (95% CI 25.45-106.54) and sROC AUC of 0.936 (95% CI 0.896-0.979) and differentiate metastatic from non-malignant nodes with DOR of 39.45 (95% CI 16.92-92.18) and sROC AUC of 0.929 (95% CI 0.873-0.966).
CONCLUSIONS: Quantitative assessment of ADC can help with differentiation of suspicious cervical lymph nodes, particularly in those patients without prior history of malignancy or unknown primary cancer site.
引用
- Payabvash S, Brackett A, Forghani R, et al. Differentiation of lymphomatous, metastatic, and non-malignant lymphadenopathy in the neck with quantitative diffusion-weighted imaging: systematic review and meta-analysis. Neuroradiology. 2019. PMID: 31175398. doi:10.1007/s00234-019-02236-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。